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Molecular dynamics simulations are used in this work to probe the structural stability and the dynamics of engineered mutants
of transthyretin (TTR), i.e., the double mutant F87M/L110M (MT-TTR) and the triple mutant F87M/L110M/S117E (3M-TTR), in
relation to wild-type. Free energy analysis from end-point simulations and statistical effective energy functions are used to analyze
trajectories, revealing that mutations do not have major impact on protein structure but rather on protein association, shifting
the equilibria towards dissociated species. The result is confirmed by the analysis of 3M-TTR which shows dissociation within the
first 10 ns of the simulation, indicating that contacts are lost at the dimer-dimer interface, whereas dimers (formed by monomers
which pair to form two extended 𝛽-sheets) appear fairly stable. Overall the simulations provide a detailed view of the dynamics and
thermodynamics of wild-type and mutant transthyretins and a rationale of the observed effects.
1. Introduction
1.1. TTR: Origin and Function. Formerly known as prealbu-
min, transthyretin (TTR) is a 55 kDa globular oligomeric
protein made up by four identical monomeric units (I-IV, see
Figure 1(a)) each composed of 127 amino acid residues. Before
being released into plasma, TTR is principally produced in
liver, choroids plexus, and retina [1–4]. It is mainly a carrier
protein that binds to retinol binding protein (RBP) to trans-
port vitamin A in plasma and represents the leading trans-
porter of thyroxine (T4) in cerebrospinal fluid (CSF) [5–7].
1.2. TTR: Structure. The 3D-conformation of all TTR-tetra-
mers displays high degree of symmetry as shown at high
resolution by Blake and coworkers [8] and Ho¨rnberg et
al. [9]. TTR is an overall 𝛽-sheet protein with a small 𝛼-
helix domain between strands E and F (see Figure 1(a)).
Its structure is highly ordered with a flexible N-terminal
region that could not be resolved in many crystallographic
studies. In each TTR monomer, about 45 % of residues
are arranged in a sandwich immunoglobulin-like topol-
ogy made up by two four antiparallel-strand 𝛽-sheets; the
inner sheet DAGH is opposed to the outer sheet CBEF. Its
secondary structure also exhibits a short 𝛽-strand portion
A∗ (see Figure 1) which is antiparallel (folded back) to
strand A through a 𝜋-turn (i+5) and which is involved in
dimer-dimer contact [10]. The dimer of monomers I and
II (Figures 1(b) and 1(c)), also known as primary dimer,
is the crystallographic asymmetric unit structurally sym-
metric to the dimer of monomers III-IV. It is stabilized by
a network of six main chain hydrogen bond interactions
established by three pairs of residues (A120(NH)󴀗󴀰(OC)Y114,
T118(NH)󴀗󴀰(OC)Y116, Y116(NH)󴀗󴀰(OC)T118) at the HH’
interface (Figure 2). Monomer I inner sheet DAGH forms
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Figure 1: Cartoon view of tetrameric (a) and dimeric ((b) and (c)) assemblies of WT-TTR. Residues involved in the mutation (F87 (orange),
L110 (cyan), and S117 (purple-blue)) are shown explicitly (stick representation) as well as the label of different 𝛽-stranded regions schematised
in Figure 2, PDB id 1F41 [9].
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Figure 2: Topology arrangement of main chain-main chain hydrogen bonds (blue lines) within wild-type monomeric subunits and at
monomer-monomer interfaces H-H’ (Figure 1(b)) and F-F’ (Figure 1(c)). Letters A to H designate the 𝛽-strands in one monomer while
H’ and F’ belong to the other monomer of the same dimer. Red arrows indicate the connection between strands and show the loop regions
and blue ones go from donor (NH) to acceptor (OC). Coloured residues (yellow) are the ones involved in the mutation and 𝛼 is the helical
region between strands E and F.
with its homologue H’G’A’D’ in monomer II a kind of
symmetric antiparallel pseudo-continuous eight-strand 𝛽-
sheet centered on HH’ (DAGH-H’G’A’D’), Figure 1(b) [10,
11]. At the opposite side, the pseudo-continuity in outer
sheets CBEF-F’E’B’C’(Figure 1(c)) is rather loose and only
4 backbone hydrogen bonds (F87(CO)󴀗󴀰(HN)T96 and
E89(NH)󴀗󴀰(OC)V94) are established (Figure 2). While
dimers are mainly kept together by hydrogen bonds at
monomer-monomer interface, tetramers become the dimers
of dimers essentially stabilized by hydrophobic contacts
established within neighbouring subunits at the dimer-dimer
interface via AB-GH loop interactions involving mainly
residues L17, A19, V20, L110, P113, T119, and V121.
1.3. TTR-Related Amyloidosis. TTR-related amyloidosis can
be inherited in the case of genetic mutations or can be
nonhereditary when it is due to wild-type (WT-TTR) [12].
WT-TTR amyloidosis also termed senile systemic amyloido-
sis (SSA) is the prevalent form of TTR amyloidosis which
principally affects the heart. It develops with ageing and
requires TTR tetramer dissociation and partial unfolding.
Mutation-induced TTR amyloidosis is instead associated
with familial amyloid polyneuropathy (FAP) which impacts
essentially on peripheral nervous system and familial amyloid
cardiomyopathy (FAC) with broad implication on heart [7,
12]. The interconnection between protein structure and sta-
bility and its capability to form amyloid fibrils havemotivated
several structural studies. To date, about 80 point mutations
have been correlated to human inherited amyloidosis [13].
1.4. Designed Mutants. WT-TTR displays a very stable
tetrameric molecular assembly. It is established that its
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structure is resistant to dissociation at physiological concen-
trations within the pH range 5-7 [14]. Several amyloid fibril
formation models have been proposed and reviewed [15–
17]. However, there is almost a consensus that the common
mechanism involves the dissociation of the native tetrameric
TTR into unstable but folded monomers, followed by local
unfolding of the latter intomultiple nonnative amyloidogenic
intermediate states that self-assemble in solution [2, 6, 15–
18]. Furthermore, evidence has been provided pointing to the
dissociation of the native tetramer as the rate-limiting step
towards aggregation [5, 19–22].
Therefore knowledge of the dynamics and thermody-
namics of dissociation of TTR native structure is an impor-
tant issue as tetramer dissociation, monomer misfolding,
and self-assembly of amyloidogenic monomers into amyloid
and other aggregate morphologies are known to be linked
to several human degenerative diseases. Specifically, TTR
represents one of the few examples whereby it was possible
to devise a drug for TTR amyloidogenesis [23] that acts
through the stabilization of a native structure, thus indicating
that thermodynamics studies and modeling of tetramer
dissociation are a very important target.
To mimic the pathological situation, previous site-
directed mutagenesis, namely, mutation F87M/L110M (MT-
TTR), was carried out to promote the dissociation of TTR
tetramer into monomers [5]. To further shift the equilibrium
towards monomers to obtain a more homogeneous dissoci-
ated species, an additional amino acid replacement has been
introduced in MT-TTR molecule (S117E) [24]. Indeed, the
latter mutant containing three mutations (3M-TTR) proved
to be markedly more prone to in vitro monomerization
in comparison with the double mutant MT-TTR, whose
tetrameric states could be recovered by Tafamidis binding, at
variance with 3M-TTR [24].
The three mutations are not reported in the ClinVar
database [25], although pathological mutations do occur in
neighbouring residues.
1.5. TTR AmyloidosisTherapeutics. Asmentioned previously,
the dissociation of TTR tetramer is believed to be the
initial step into its fibrillation pathway [26]. Therefore, many
strategies to TTR amyloidosis prevention exploit its ability
to bind small molecules in the T4 binding channel (see
Figure 1(a)), mimicking its hormone binding capability,
thereby producing kinetic stabilization of the tetramer [27,
28]. Other clinical remedies to FAC and FAP amyloidosis
often employ organs transplantation (e.g., liver), even though
not all the affected organs can be transplanted (e.g., choroids
plexus, where TTR is produced as well [29]). Furthermore,
additional treatments against TTR amyloidosis have been
experimented, among which there are gene therapy [30] and
the resorption of amyloid deposits [31].
The aim of this work is to provide a rationale of the
observed dynamics and thermodynamics of the wild-type
and mutant transthyretin based on atomistic molecular
dynamics simulations. The methods applied here show the
relative stability of monomers, dimers, and tetramers and
provide a description of both enthalpic and entropic contri-
butions taking advantage of recently developed methods.
2. Materials and Methods
2.1. Free Energy from End-Point MD Simulation. The free
energy of a system, with respect to some reference state,
can be in principle deduced from conformational samples
obtained, e.g., in a molecular dynamics simulation.
For a well equilibrated system, the enthalpy can be esti-
mated as an ensemble average of the potential energy over a
set of conformations from the MD trajectory. The bottleneck
in obtaining the Gibbs free energy is the proper modeling of
the entropic part and in particular of the solvation entropic
effects.
In order to obtain free energy estimates all molecular
dynamics snapshots have been analyzed using the GBSA
implicit solvent model as implemented in a home-written
version of the software Bluues [32, 33].
The Gibbs free energy in the context of implicit solvent
MD simulation has been discussed in reviews [34–37]. We
follow here our recent perspective on the issue [37]. The free
energy of a system may be written as
Δ𝐺0𝐴
= −𝑘B𝑇 log(∫ exp [−𝛽 (𝑈 (r𝐴) + ΔW (r𝐴, 𝑇))] 𝑑r𝐴)
(1)
where 𝑈 is the solute potential, 𝑈 + ΔW is the potential
of mean forces (with ΔW the solvation energy), 𝑘B is the
Boltzmann constant, and 𝑇 is the temperature.
The above expression can be rearranged and written as
the sum of an entropic term involving only solute coordinates
and an ensemble average including also solvent enthalpy and
entropy:
Δ𝐺0𝐴 = ⟨𝑈 (r𝐴) + ΔW⟩ − 𝑇Δ𝑆𝑐𝑜𝑛𝑓 (2)
where Δ𝑆𝑐𝑜𝑛𝑓 is the configurational entropy of the solute.
The above formula constitutes the basis of free energy
estimation from end-point simulations detailed in the fol-
lowing sections. The solute vacuum potential energy was
obtained by selecting the solute from the trajectories and
recalculating the energy involving only solute terms.
The solute potential energy and the solvation energy were
calculated from molecular dynamics snapshots of the solute.
First the molecular surface was generated using the program
MSMS by Sanner [38]; then the vertices and normals to the
surface were read by the program Bluues [32, 33] and used
to compute Generalized Born radii and to compute solvation
energy according to the GB model [39].
The solvent accessible surface outputted by MSMS was
used to compute the apolar contribution to the solvation
energy using a surface tension constant of 5 cal/(A˚2 mol)
[40, 41].
For entropic contributions Δ𝑆𝑐𝑜𝑛𝑓 is rewritten in terms of
solute conformational probability density:
Δ𝑆𝑐𝑜𝑛𝑓 = −𝑅 < log (𝜌 (r𝐴, 𝑇)) > (3)
where 𝜌(r𝐴, 𝑇) is the density in configurational space. The
latter is estimated using the nearest neighbour method [42–
50]. The basic idea of the method is to provide a description
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of the configuration in a space where a metric is defined (e.g.,
the torsional angle space) and then use the distance to the 𝑘𝑡ℎ
nearest neighbour of each sample to estimate the density of
probability around that sample. When this is done with the
caveats discussed in depth by Demchuk and coworkers [42],
the average of the estimated density at each sample provides
the estimate of the configurational entropy by the equation
above.
In order to cope with the high dimensionality of the
space, with largely decoupled degrees of freedom, the mutual
information expansion (MIE) method [44, 45] and the
maximum information spanning treemethod (MIST) [51, 52]
were proposed.
The reader is referred to the cited literature for details on
the methods.
Entropic contributions due to changes in the internal
degrees of freedom were calculated using the nearest neigh-
bour and the MIST methods as implemented in our pro-
gram PDB2ENTROPY (URL: https://github.com/federico-
fogolari/pdb2entropy) which will be described elsewhere.
Rotational and orientational entropywas computed using
the nearest neighbourmethod in the Euclidean space approx-
imation, which is an excellent approximation for the number
of samples at hand, as described previously [50]. The calcu-
lation is implemented in our program PDB2TRENT (URL:
https://github.com/federico-fogolari/pdb2trent) which will
be described elsewhere.The same approach has been used by
us before [53].
2.2. Molecular Models. The X-ray structures used as starting
configuration are the wild-type transthyretin (WT-TTR)
taken from the RCSB Protein Data Bank (PDB) [54], PDB
id: 1F41 [9], solved at the resolution of 1.3 A˚; the double
point mutant (MT-TTR) F87M/L110M (PDB id: 1GKO [5])
resolved at 2.10 A˚; and the in silico engineered triple mutant
F87M/L110M/S117E (3M-TTR).The structure of triplemutant
was obtained from that of MT-TTR mutating the S117
by E (S117E) using the protein modeling software Swiss-
PdbViewer [55].TheN-terminal residues 1-9 andC-terminals
126-127 are not present in the structure and were not mod-
eled. Tetramers were built from deposited asymmetric units
(dimers) by applying crystal symmetry operations. All the
crystallizationwatermolecules were removed prior to run the
simulations.
2.3. Molecular Dynamics Simulations. A set of independent
simulation runs of different length ranging from 50 to 250
ns were performed on monomer, dimer, and tetramer of
wild-type and mutant structures of TTR employing either
CHARMM27 all atoms force field with CMAP correction
[56] or amber99sb-ildn molecular mechanics force field [57].
The protein atoms were placed at the center of a cubic box;
the system was solvated using the 3-site rigid water model
TIP3P [58–60]. In each system an equivalent number of
solventmolecules were replaced byNa+ counterions to obtain
a neutral system.
The systems were first minimized using the steepest
descent minimization algorithm with a minimization step
size of 0.1 nm and a maximum convergence force of 1000.0
kJmol−1nm−1. The equilibration phase was done in 2 steps:
100 ps inNVT ensemble followed by 100 ps inNPT ensemble.
During the first equilibration stage, the leap-frog integrator
with integration time-step of 0.002 ps was used to update
the changes in the system. Particle Mesh Ewald summation
[61, 62] accounted for long-range electrostatics interactions.
The temperature was equilibrated to a reference value of
300 K using the velocity rescaling (modified Berendsen
thermostat) [63] with a coupling constant of 0.1 ps. Short-
range electrostatics and van der Waals interactions were
truncated with a 10 A˚ cutoff. All bonds were constrained
with the LINCS algorithm [64]. In NPT equilibration stage,
the previous parameters were still used and the pressure was
stabilized to 1.0 bar using the Parrinello-Rahman pressure
coupling [65, 66] with a coupling constant of 2.0 ps.
2.4. Molecular Dynamics Simulation Analysis. MD trajecto-
ries were analyzed with available structural-based tools in
Gromacs-5.0.4 [41, 67]. The thermodynamic stability of the
tetrameric systemswas further processed using theAcademic
License version of the bioinformatics tool FoldX [68], using
the commands Stability and AnalyseComplex, respectively, to
gain information on protein stability and interacting interface
free energies. In all the cases, the values were averaged over
the whole simulation trajectory. AnalyseComplex command
outputs the Gibbs interacting free energy of binding for
a complex formation (folding), say AB (𝐴 + 𝐵 → 𝐴𝐵),
computed asΔΔ𝐺AB = Δ𝐺AB−(Δ𝐺A+Δ𝐺B), whereΔ𝐺 is the
free energy of folding. Similarly the statistical effective energy
function proposed by Berrera et al. [69], referred hereafter as
BMF, has been used with home-written routines.
The computation of conformational entropy employs the
nearest neighbour formalism whose rationale is the estima-
tion of the local probability density around each sample by
counting its number of neighbours within a hypersphere of
radius equal the distance from that sample to its 𝑘th nearest
neighbours. Thus, the values discussed in the results section
are averaged for the 10th nearest neighbour, set as default for
the routines previously cited. Conformational entropies were
calculated over 5000 frames.
Pictures were either collected with PyMOL [70] or VMD
[71], secondary structureswere assigned usingDSSP program
[72], and H-bonds occupancy was computed using the
readHBmap.py tool reporting only H-bonds with occupancy
greater than 10 %.
3. Results and Discussion
3.1. Monomer to Dimer and Dimer to Tetramer Associations.
The enthalpic contributions to the association of monomers
and dimers were assessed considering both single species
simulations and detaching from the tetramer simulations
dimers first and then monomers. In both cases favorable
protein-protein interactions appear largely overestimated by
the force-field used, as recently observed also for other
systems [73, 74]. The “enthalpic” contributions encompass
the solvation energy which includes also the entropy of the
solvent. For this reason the term enthalpy is used rather freely
only with the purpose of separating the terms related to the
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Table 1: Summary of potential and solvation energy average and conformational entropy changes computed using the nearest neighbour
approach from monomer (M) to dimer (D) and from dimer to tetramer (T).
Δ𝐻 (kcal mol−1) -TΔ𝑆conf (kcal mol−1) -TΔ𝑆rt (kcal mol−1)
WT-TTR 2M→D -49.7 ± 3.7 4.0 ± 0.8 10.4
2D→T -81.0 ± 2.9 16.2 ± 0.5 11.3
MT-TTR 2M→D -49.8 ± 2.6 7.6 ± 0.8 10.4
2D→T -77.2 ± 6.5 14.8 ± 1.1 10.3
potential ofmean force and those computed from the analysis
of conformational samples.
The enthalpy of two wild-type (mutant) monomers asso-
ciating in a dimer computed by the ensemble averages of the
potential is -49.7 (-49.8) kcal/mol and that of two dimers
associating in a tetramer is -81.0 (-77.2) kcal/mol leading to
a very favorable -180.4 (-176.8) kcal/mol association enthalpy
for tetramerization.
The reduction in conformational entropy (i.e., changes
in entropy due to internal degrees of freedom) from two
monomers to dimer and from two dimers to tetramer,
computed considering only correlations within each residue,
is -6.7 (-12.8) e.u. and -27.2 (-24.8) e.u., respectively, thus
opposing tetramerization, at 300K, by 24.3 (30.1) kcal/mol.
The rotational-translational entropy (Δ𝑆𝑟𝑡) was computed
for monomer-monomer and dimer-dimer association, using
the Euclidean approximation for the rotational-translational
space, resulting in 19.0 (17.3) e.u. for the dimer-dimer
association and 17.5 (17.5) e.u. for the monomer-monomer
association.
Rotational-translational entropy thus opposes tetramer-
ization by 32.2 (31.2) kcal/mol.
Overall, therefore, the large favorable enthalpy (likely
to be overestimated here) is opposed by conformational
and rotational-translational entropy which we can estimate
to result in total 56.5 (61.3) kcal/mol. These results are
summarized in Table 1.
The detailed analysis of the terms contributing to the
enthalpy shows that covalent energy terms contribute very
little to the energy difference and Lennard-Jones terms make
the largest favorable contribution to association, whereas
favorable electrostatic and unfavorable desolvation contribu-
tions provide an overall unfavorable but smaller (about one-
third in absolute value) contribution.
The analysis provides thus a lower stability of the tetramer
assembly for the mutant relative to the wild-type protein.The
uncertainties of the methodology are however comparable to
this difference.
3.2. Statistical Effective Energy Functions Analysis. The struc-
tural and thermodynamic stability of both mutant structures
in relation to wild-type was further probed thanks to two
independent bioinformatic tools, i.e., FoldX [68] (Figure 3(a))
and the statistical effective energy function BMF [69] (Fig-
ure 3(b)).This analysis provides a complementary view of the
thermodynamic picture presented above.
We computed the folding free energy differences between
mutants andwild-type (ΔΔG=ΔGmutant-ΔGwild-type) through-
out the tetramer-unfolded monomers equilibrium, Figure 3.
Somewords of caution are due when presenting the following
data because the energy functions used take into account
implicitly the entropy loss from internal degrees of free-
dom but not that arising from external degrees of freedom
as implied by the tetramer to dimers and the dimers to
monomers transitions.
Finally, notwithstanding the fluctuations and differences
in underlying principles and datasets, the two approaches
used here are consistent with each other as detailed below.
Thepanels (A) in Figures 3(a) and 3(b) point out that both
mutants have positive difference in free energy as compared
to WT-TTR and thus are less stable. Their average free
energy ΔΔGT computed using BMF (FoldX) is +0.3 and +7.8
kcal/mol (+2.5 and +15.6 kcal/mol), respectively, forMT-TTR
and 3M-TTR, confirming the decreased tetramer thermo-
dynamic stability upon mutations, significant in the case of
3M-TTR.This result is consistent with previously determined
experimental data, which indicated that monomers of 3M-
TTR, at variance with MT-TTR, could not reform tetramers
upon the addition of Tafamidis, a known stabilizer of the
tetrameric form [24].
In order to track down all contributions, ΔΔG’s values
were computed and reported in subsets (B, C, and D) of
Figures 3(a) and 3(b) for all the steps in the equilibrium
pathway from tetramers to unfolded monomers (required
before monomers self-assemble into amyloid fibrils) through
dimers.We calledΔΔGD,ΔΔGM, andΔΔGunfM the free energy
for the dissociation of tetramers into dimers (T→D), for
the formation of folded monomers from dimers (D→M),
and for the unfolding of individual monomers (M→Munf ),
respectively. Based on simulations we guessed that tetramers
first break down into dimers I/II and III/IV, i.e., along the C2
crystallographic axis, instead of I/III and II/IV.Thus,ΔΔ𝐺D =Δ𝐺D − Δ𝐺T (dissociation free energy at I/II-III/IV dimer-
dimer contact), ΔΔ𝐺M = Δ𝐺M − Δ𝐺D (dissociation free
energy at I-II and III-IV monomer-monomer contacts), and
ΔΔ𝐺unfM = Δ𝐺unfM − Δ𝐺M.ΔΔGD using BMF (FoldX) average is -1.1 and -8.7
kcal/mol (-2.5 and -26.3 kcal/mol) for MT-TTR and 3M-
TTR, respectively, relative to WT-TTR. This means both
equilibriums are shifted towards the right (subsets (B) in
Figures 3(a) and 3(b)), i.e., the formation of dimers. The
quite high (absolute) value displayed by 3M-TTR indicates
the propensity of tetrameric assembly of the latter structure to
dissociate into dimers I/II and III/IV as compared to thewild-
type protein. Considering the dimer-monomer equilibrium
(subsets (C) in Figures 3(a) and 3(b)), ΔΔGM’s average using
BMF (FoldX) is -1.2 and -2.5 kcal/mol (-3.3 and -5.2 kcal/mol)
over the trajectory for MT-TTR and 3M-TTR, respectively,
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Figure 3: Folding free energy difference between mutants and native wild-type along the simulation trajectory and throughout the tetramer-
unfolded monomer equilibrium. Panels (a) and (b) refer to FoldX and BMF results, respectively. In the case of tetramer (A), ΔΔGT is the
global stability free energy change of tetramers, i.e., the free energy required to fold the tetramers from their unfolded monomers. Subscripts
𝑚𝑢𝑡 and𝑤𝑡 are, respectively, mutant (MT-TTR or 3M-TTR, with their simplified notations𝑚𝑡 and 3𝑚) and wild-type (WT-TTR). ΔΔGD (B)
is the free energy necessary to form the dimers from tetramers (T→D). ΔΔGM (C) is the free energy involved in the dissociation of dimers
into folded monomers (D→M) and ΔΔGunfM (D) is the free energy of unfolding of individual monomers (M→ Munf ).
relative to WT-TTR. The values are however rather limited
compared to the overall stability computed usingBMF for the
process of fourWT-TTRmonomers associating into 2 dimers
(-14.2 kcal/mol).
Finally the change with respect to WT-TTR in folding
free energy of monomers has been computed. Both BMF
and FoldX predict a shift towards the formation of more
stable monomers for both mutants ΔΔGunfM > 0; i.e., the
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Figure 4: Ramachandran plots of individual residues at individual point mutations.
equilibrium M 󴀘󴀯 M𝑢𝑛𝑓 is shifted towards the folded form
(panels (D) in Figures 3(a) and 3(b)).The unfavorable forma-
tion of unfolded monomers in both mutants strongly cor-
relates with the secondary structure analysis displayed in
Figure 5 showing that notwithstanding the enhanced dissoci-
ation of tetramers intomonomers through dimersmonomers
remain stable (folded). Besides, this result would strongly
suggest that both monomers of our mutant variants are non-
amyloidogenic, as is known as far as MT-TTR is concerned
[5].
3.3. Localised Structural Transitions. Local conformational
transitions were assessed by computing the dihedral phi (𝜙)
and psi (𝜓) angles of individual residues involved in the
mutation and represented as Ramachandran plots, Figure 4.
TheX-ray (𝜙∘, 𝜓∘) dihedral angles for residue 87 are (-84,-
55), (-84,-40), and (-85,-41) in WT-TTR, MT-TTR, and 3M-
TTR, respectively. The same values reported from simulation
are as follows: (-75±12, -46±9), (-80±16, -44±13), and (-91±15,
-38±15), Figure 4(a).These latter lie in the allowed regions for
𝛼-helical secondary structure, −89 < 𝜙 < −39 and −66 < 𝜓 <
−16 [75], confirming that no secondary structural transition
occurred at this position.
The 𝜙/𝜓 dihedral angles of L110 and M110 residues
Figure 4(b) look even more similar than the previously
observed ones. No major deviation was observed in indi-
vidual monomers and the dihedral angles for residue 110
in each variant keep close to the equilibrium value. The
average reported simulation values are (-122±11, 122±8), (-
116±12, 122±10), and (-117±11, 119±10), respectively, in WT-
TTR, MT-TTR, and 3M-TTR. Indeed, these fall into the
region corresponding to 𝛽-sheet secondary structure, −180 <
𝜙 < −45 and 45 < 𝜓 < 225 [75], and imply that no structural
transition is seen in the process of point mutation L110M.
In Figure 4(c), while both TTR variants are displaying
nearly the same 𝜙/𝜓 averages, (-137±10, 140±9), (-136±16,
134±12), and (-131±17, 135±11), it is seen that a distinct region
is being accessed by mutant variants. The region is defined
by −40 < 𝜙 < 70 and 30 < 𝜓 < 140 corresponding to left
handed helix conformation. The transition is observed only
once for both MT-TTR and 3M-TTR within the first 10 ns of
the simulation possibly as a transient adaptation to in silico
mutation of residue 110.
3.4. Secondary Structural Changes. The illustration of
dynamical processes in our systems during the simulations
was done by computing the secondary structure, Figure 5.
The latter analysis was performed thanks to the DSSP
program which determines the existence of hydrogen bonds
as a criterion for the presence of secondary structure [72].
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Figure 5: Time-based secondary structure analyses. From top to bottom the secondary structures ofWT-TTR (a),MT-TTR (b), and 3M-TTR
(c) are, respectively, displayed. Colours were used to distinguish between secondary structure types and letters A to H stand for 𝛽-strands
and 𝛼 is the helical portion between E and F strands.
While dihedral (𝜙, 𝜓) angles (Figure 4) were useful for assess-
ment of local structural changes, secondary structure is able
to highlight the global structural changes.
In Figure 5 we can see that the helical region exhibits
large structural fluctuations and even gets disrupted from
time to time, like in monomer II for all the TTR vari-
ants. F-strand undergoes some structural fluctuations at its
beginning, particularly in monomers I, III, and IV. In G-
H loop, some part of the structure is being converted from
bend to 𝛽-turn and conversely. D-strand displays quite high
structural fluctuations in monomers II and IV of WT-TTR,
in monomers II and III of MT-TTR, and in all monomers for
3M-TTR. A- and C-strands make the most stable parts of the
molecules. E-strand in the vicinity of 𝛼-helix is showing some
fluctuations in monomers I, III, and IV of all the variants. In
spite of structural fluctuations exhibited by major parts of the
tetrameric molecular assemblies, Figure 5 clearly points out
that monomers are nevertheless remaining folded; i.e., they
preserve essentially their secondary structures.This observa-
tion is supported by the fact that no evident disruption and
secondary structure conversion are seen in the core region
(made by the 𝛽-strands) of the different systems studied.
3.5. Intra- and Interchains Hydrogen Bonds Occupancy. In
order to understand the mechanism of 3M-TTR dissocia-
tion we computed the H-bonds occupancy along the MD
trajectory considering both main chain-main chain, main
chain-side chain, and side chain-side chain hydrogen bonds,
at monomer-monomer and dimer-dimer interfaces. Figure 6
summarizes the occupancies of the interactions that were
identified to significantly perturb the tetrameric assembly of
TTR upon mutations. It should be noted that for 3M-TTR
the occupancy reflects an average of both (starting) associated
and dissociated configurations.
In Figure 6, seven major H-bonds (with ⩾ 80 % occu-
pancy) can be seen almost symmetrically distributed in
both dimers, three at I-II interface and four at III-IV inter-
face. These are being lost in 3M-TTR with their average
occupancy dropping below 40 %. These include the inter-
actions Y114(CO)-A120(HN) and A120(HN)-Y114(O) (main
chain-main chain) and T119(H𝛾1)-S115(O𝛾) and S115(H𝛾1)-
T119(O𝛾1) (side chain-side chain). Most of them are located
in the H-strand and some in the G-H loop.
At the interface of symmetric units (I-III and II-IV) there
is a significant loss in H-bond occupancy in 3M-TTR, in
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for monomer and dimer while I to IV are different monomers.
particular at II-IV interface. The occupancies of 22GLY(O)-
122VAL(HN) and 122VAL(HN)-22GLY(O) (main chain-
main chain) located in H-strand and A-B loops lie under the
10 % (Figure 6). Interestingly, it is worth mentioning that, in
3M-TTR, several side chain-side chain interactions are being
formed following dissociation and subsequent temporary
association. These involve many inner sheets residues like
K15, R104, and E117, most of which show significant deviation
from the starting WT-TTR X-ray structure.
Analysis of hydrogen bonds connectivity confirms the
pivotal role of such networks in preserving the protein
integrity, typically in some dedicated portions, in this case
H-strand, G-H, and A-B loops. These susceptible portions of
TTR that build up the monomer-monomer and dimer-dimer
interfaces are definitely playing a key role in destabilization
of tetrameric subunits of TTR, especially in the case of 3M-
TTR. Indeed, the disappearance of H-bonds in the previously
mentioned domains along the timescale of the simulations
brings a possible explanation on the integrity loss of tetramers
in 3M-TTR.
3.6. Mechanism of Tetramer Dissociation. The path of dis-
sociation of dimers in 3M-TTR may be followed during
the simulation (Figure 7). The first step in conformational
transition is the dissociation at the interface I/IV involving
residues 17-24 and 110-123, including position 117 mutated to
glutamic acid in 3M-TTR at variance with MT-TTR where
the corresponding residue is a serine. The transition appears
driven by the electrostatic repulsion of the pairs of acidic
residues E117 close in each dimer. First the interface is
weakened (up to 15 ns) and disrupted (20 ns); then both I/II
and III/IV dimers remain rigid. Dimer III/IV rotates formost
of the simulation about a hinge centered on salt bridges E51
(I)-R104 (III) and R104 (I)-E51 (III) and hydrogen bonds E51
(III)-T123 (I) and at the end only about the latter two interac-
tions.The final (possibly transient) conformation is stabilized
by salt bridges E117 (I)-R21 (III) andK15-E54 at I/III interface.
Other interactions at II/III interface are mostly hydrophobic.
No sign of dissociation or conformational rearrangement at
dimers is observed during the simulation. For both dimers
the proximity of E117 acidic groups should result in repulsion
which is however reduced by ionic interactions.
4. Conclusions
Molecular dynamics simulations were used in this work
to probe the structural stability and the dynamics of engi-
neered mutants of transthyretin (TTR), i.e., the double
mutant F87M/L110M (MT-TTR) and the triple mutant
F87M/L110M/S117E (3M-TTR), in relation to wild-type. The
analysis of trajectories reveals that mutations do not have
major impact on protein structure, and the thermodynamic
analysis confirms this picture.
Estimation of the free energy from end-point sim-
ulations shows that the two mutations F87M/L110M on
monomers/dimer and dimers/tetramer equilibria favor the
dissociation.The results are however within the uncertainties
of the methodology.
Consistent with the latter analysis evaluation of stability
with the statistical effective energy functions FoldX and
BMF shows that the mutations and the triple mutations
F87M/L110M/S117E affect differently the same equilibria and
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Figure 7: Snapshots from 3M-TTR 100 ns molecular dynamics simulations. Chains I and III are shown in red; chains II and IV are shown in
yellow. Chains I and II, in the lower part of the tetramer, are used for superposing all snapshots on the starting conformation.
the stability of the monomers. The latter is almost not per-
turbed by mutations, whereas the equilibria are shifted
towards the dissociated species relative to wild-type TTR.
This is confirmed by the analysis of 3M-TTR which shows
partial dissociation within the first 20 ns of the simulation,
implying that contacts are lost at the dimer-dimer interface,
whereas dimers appear fairly stable.
Overall the simulations provide a detailed view of the
dynamics and thermodynamics of wild-type and mutant
transthyretin and a rationale of the observed effects.
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